Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agoni...
Leadership
Lawrence M. Blatt MBA, Ph.D.
CEO, President & Chairman of the Board
Lesley Ann Calhoun CPA
Executive VP, CFO & COO
Julian A. Symons DPHIL
Executive VP & Chief Scientific Officer
Nikhil Aneja
Principal Accounting Officer
Laura Kavanaugh
VP & Head of Legal
Kristina Engeseth M.B.A.
Senior VP and Head of People & Culture
Sushmita M. Chanda DABT, Ph.D.
Executive Vice President & Chief Development Officer
David B. Smith Ph.D.
Executive VP & Head of Chemical Operations
Tse-I Lin Ph.D.
Senior VP of Early Compound Development & Belgian Site Head
Kieron Wesson Ph.D.
Vice President & Head of Chemistry Manufacturing Controls
